# Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke

> **NCT01910363** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of Tokushima** · enrollment: 30 (estimated)

## Conditions studied

- Lower Limb Spasticity After Stroke

## Interventions

- **DRUG:** A2NTX
- **DRUG:** BOTOX

## Key facts

- **NCT ID:** NCT01910363
- **Lead sponsor:** University of Tokushima
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-07
- **Primary completion:** 2014-01
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01910363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01910363, "Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01910363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*